ClinicalTrials.gg
RecruitingNCT05657847Updated Dec 20, 2022

Novel Complex Radiodiagnostics of Peripherial Arthropathies

An observational study in Arthritis, Rheumatoid, Arthritis, Psoriatic and Crystal Arthropathies, sponsored by Semmelweis University. Recruiting at 3 sites in Hungary. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2022-12-20.

Sponsored by Semmelweis University · Observational

How we know

From the registry’s dates

  • Started Mar 2022; still recruiting 4 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 204 studies in Arthritis, Rheumatoid with a site in Hungary — 4 open to participants now, 11 under way, 2 of them phase 3. Arthritis, Rheumatoid · Hungary.

Planned enrollment
3rd of 11
500 · median 353
Started
2022
with 3 others
Observational
11 of 204
2 open now
Primary completion
2027-02
later than 5 of 10 live
Registered
193rd of 204
by date

Among the 204 studies in Arthritis, Rheumatoid with a site in Hungary, this one is the 3rd largest by planned enrollment of the 11 observational ones that give a count, is one of 4 that started in 2022, is one of 11 observational ones, reaches primary completion later than 5 of the 10 other live ones, and was the 193rd registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

4 of the 204 studies in Arthritis, Rheumatoid with a site in Hungary are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Hungary have not opened yet or have stopped. Only those recruiting at a site in Hungary →

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 204 studies in Arthritis, Rheumatoid with a site in Hungary, or all of them as a file.
02

Study summary

Chronic peripherial arthritides are common diseases with soaring public health consequences. Our goal is to assess the role of photon-counting detector computed tomography in the diagnostics of peripherial arthropathies.

Read the detailed description

Background:

Chronic peripherial arthritides include immune-mediated (rheumatoid arthritis, psoriatic arthritis) and crystal deposition diseases (gout, pseudogout, hydroxiapatite-deposition disease).

Conventional radiographs are utilized to screen arthritis-associated deformities, bone erosions and joint space narrowing. MRI is able to detect bone marrow edema, synovitis and the swelling of soft tissues. Sonography can also detect synovitis and soft tissue involvement but does not provide information about bone marrow edema and poorly assess erosions. Photon-counting detector computed tomography (PCD-CT) is a novel type of CT device which provides many advantages like improved signal-to-noise ratio, intrinsic spectral information, lower radiation exposure, and better spatial resolution. PCD-CT is a type of X-ray computed tomography in which X-rays are detected using a photon-counting detector. These detectors are able to directly transform X-ray photons into electrical signals. Compared to previous generation scintillation detectors, photon-counting detectors have several advantages: being able to count the charges created by individual x-ray photons and measuring their energy level also providing multi- energy spectral sensitivity. 0.2 mm slice thickness potentiates the detection of bone erosionss. Collagen-rich structures like cartilage, ligaments, and tendons are easier to identify on PCD-CT images. Bone marrow edema can be visualized with virtual non- calcium reconstruction. PCD-CT could both detect and differentiate cristal deposits.

Aims: To assess the possible role of PCD-CT technique in the diagnostics of peripherial arthropathies.To compare the role of PCD-CT in the detection of arthritis-related pathologies with other imaging modalities like MRI and conventional radiography.

03

Conditions studied

  • Arthritis, Rheumatoid
  • Arthritis, Psoriatic
  • Crystal Arthropathies

Keywords

  • photon-counting detector computer tomography, magnetic resonance imaging, radiography, rheumatoid arthritis, psoriatic arthritis, crystal arthropathies
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adults suffering from peripherial arthritis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Rheumatoid arthritis (EULAR/ACR Criteria) / Psoriatic arthritis (CASPAR Criteria)/ Crystal arthropathies
  • signed

Exclusion criteria

Exclusion Criteria:

  • age: \<18 years, > 100 years
  • pregnant
  • breastfeeding
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Rheumatoid arthritis

    Rheumatoid arthritis patients. (American College of Rheumatology (ACR) 1987, ACR/European League Against Rheumatism (EULAR) \>18 years Imaging studies: CT and X-ray/MRI/US Physical examination by the rheumatologist and laboratory tests which are conventionally necessary for the diagnosis (including RF, ACPA)

    Device: Photon-counting detector-CT

  • Psoriatic arthritis

    Psoriatic arthritis patients. (CASPAR Criteria) \>18 years Imaging studies: CT and X-ray/MRI/US Physical examination by the rheumatologist and laboratory tests which are conventionally necessary for the diagnosis.

    Device: Photon-counting detector-CT

  • Crystal arthropathies

    Crystal arthropathies patients. \>18 years Imaging studies: CT and X-ray/MRI/US Physical examination by the rheumatologist and laboratory tests which are conventionally necessary for the diagnosis.

    Device: Photon-counting detector-CT

Interventions

  • DevicePhoton-counting detector-CT

    CT scan

06

What researchers measure

Primary outcomes

  1. Bone erosions

    To assess the detection of arthritis-related bone erosions with different imaging techniques, including PCD-CT.

    Time frame: From baseline to at least 2 years

  2. Bone marrow edema and periarticular soft tissue involvement

    To assess the detection of arthritis-related bone marrow edema and periarticular soft tissue with different imaging techniques, including PCD-CT.

    Time frame: From baseline to at least 2 years

  3. Crystal deposit characterization

    To detect the different crystal deposits with PCD-CT.

    Time frame: From baseline to at least 2 years

Secondary outcomes

  1. To evaluate the performance of PCD-CT in the detection of active arthritis-related imaging findings and structural damages.

    To compare the performance of PCD-CT with different modalities in the diagnostics of peripherial arthropathies.

    Time frame: From baseline to at least 3 years

07

Study locations

3 of 3 sites recruiting
  • National Institute of Rheumatology and Physiotherapy
    Budapest, H-1023, Hungary
    Recruiting
    • Peter Vince Balint, MD, PhD, FRCP · Contactpvbalint@gmail.com · +36 1 438 8300
    • Peter Vince Balint, MD, PhD, FRCP · Principal investigator
    • Viktoria Gyergyoi, MD · Sub investigator
    • Akos Menyhart, MD · Sub investigator
  • Buda Hospital of the Hospitaller Order of Saint John of God
    Budapest, H-1027, Hungary
    Recruiting
    • Gyorgy Nagy, MD, PhD · Contactgyorgyngy@gmail.com · +36-1-438 8500
    • Gyorgy Sandor Nagy, MD, PhD · Principal investigator
    • Judit Zsuzsanna Majnik, MD, PhD · Sub investigator
    • Kinga Fritsch, MD · Sub investigator
  • Semmelweis University
    Budapest, H-1085, Hungary
    Recruiting
    • Pal Maurovich-Horvat, MD, PhD, MPH · Contactmaurovich-horvat.pal@med.semmelweis-univ.hu · +36-1-210-0307
    • Nikolett Marton, MD, PhD · Contactmarton.nikol@gmail.com · +36-30-016-4545
    • Pal Maurovich-Horvat, MD, PhD, MPH · Principal investigator
    • Nikolett Marton, MD, PhD · Sub investigator
    • Janos Gyebnar, MD · Sub investigator
    • Gyorgy Gulacsi, MD · Sub investigator
    • Rita Csercsik, MD · Sub investigator
    • Tamas Purczel, MD · Sub investigator
    • Tamas Munkacsi, MD · Sub investigator
    • Hanna Balogh, MD · Sub investigator
    • Nora Kerkovits, MD · Sub investigator
    • Csenge Poka, MD · Sub investigator
    • Norbert Nagy, MD · Sub investigator
    • Tamas Nemeth, MD, PhD · Sub investigator
08

References and documents

Publications

  • Duryea J, Dobbins JT 3rd, Lynch JA. Digital tomosynthesis of hand joints for arthritis assessment. Med Phys. 2003 Mar;30(3):325-33. doi: 10.1118/1.1543573. PubMed 12674232 ↗
  • Stamp LK, Anderson NG, Becce F, Rajeswari M, Polson M, Guyen O, Viry A, Choi C, Kirkbride TE, Raja AY. Clinical Utility of Multi-Energy Spectral Photon-Counting Computed Tomography in Crystal Arthritis. Arthritis Rheumatol. 2019 Jul;71(7):1158-1162. doi: 10.1002/art.40848. Epub 2019 May 28. PubMed 30714678 ↗
  • Adams JE, Chen SZ, Adams PH, Isherwood I. Measurement of trabecular bone mineral by dual energy computed tomography. J Comput Assist Tomogr. 1982 Jun;6(3):601-7. doi: 10.1097/00004728-198206000-00028. PubMed 7096705 ↗
  • Woodworth TG, Morgacheva O, Pimienta OL, Troum OM, Ranganath VK, Furst DE. Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review. Rheumatology (Oxford). 2017 Jul 1;56(7):1177-1188. doi: 10.1093/rheumatology/kew445. PubMed 28398508 ↗
  • Ostergaard M, Ejbjerg B, Szkudlarek M. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography. Best Pract Res Clin Rheumatol. 2005 Feb;19(1):91-116. doi: 10.1016/j.berh.2004.08.006. PubMed 15588973 ↗
  • Fukuda T, Umezawa Y, Asahina A, Nakagawa H, Furuya K, Fukuda K. Dual energy CT iodine map for delineating inflammation of inflammatory arthritis. Eur Radiol. 2017 Dec;27(12):5034-5040. doi: 10.1007/s00330-017-4931-8. Epub 2017 Jul 3. PubMed 28674965 ↗
  • Mallinson PI, Coupal TM, McLaughlin PD, Nicolaou S, Munk PL, Ouellette HA. Dual-Energy CT for the Musculoskeletal System. Radiology. 2016 Dec;281(3):690-707. doi: 10.1148/radiol.2016151109. PubMed 27870622 ↗
  • Finkenstaedt T, Manoliou A, Toniolo M, Higashigaito K, Andreisek G, Guggenberger R, Michel B, Alkadhi H. Gouty arthritis: the diagnostic and therapeutic impact of dual-energy CT. Eur Radiol. 2016 Nov;26(11):3989-3999. doi: 10.1007/s00330-016-4237-2. Epub 2016 Feb 4. PubMed 26847043 ↗
  • Willemink MJ, Persson M, Pourmorteza A, Pelc NJ, Fleischmann D. Photon-counting CT: Technical Principles and Clinical Prospects. Radiology. 2018 Nov;289(2):293-312. doi: 10.1148/radiol.2018172656. Epub 2018 Sep 4. PubMed 30179101 ↗

Individual participant data

Plan to share: Undecided — Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2022 (actual). Primary completion is estimated for Feb 2027, 58 months after the start.

Of 235 non-industry observational studies under Arthritis, Rheumatoid, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 122. This study's planned 58 months is above that.

Counting every sponsor, half of 390 studies reached it within 50 months; a quarter within 25 and three quarters within 113.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2022
First posted
Dec 20, 2022
StartActual
Mar 7, 2022
Primary completionEst.
Feb 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Dec 20, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05657847
Collaborators
National Institute of Rheumatology and Physiotherapy, Hungary, Buda Hospital of the Hospitaller Order of Saint John of God
Responsible party
Sponsor
First posted
Dec 20, 2022
Start date
Mar 7, 2022
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Dec 20, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion